Mode
Text Size
Log in / Sign up
Phase 4 N=37 Single-blind Treatment

Assessment and Augmentation of Lip Appearance in Specific Study Populations

Lip Aging · Lip Augmentation · Lip

Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcome: Primary: Change in Lip Vessel's Thickness — 0.833; 0.360 µm

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Hyaluronic acid filler (Drug)
Age
Adult, Older Adult · 21+ yrs
Sex
Female
Sponsor
Dieter Manstein, MD
Primary completion
Jul 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Lip Vessel's Thickness
0.833; 0.360
SECONDARY
Wong-Baker FACES Pain Rating Scale
2.9; 3.5
SECONDARY
Lip Fullness Measurement (Measures the Increase of Lip's Size After the Procedure)
1.14; 0.78

Summary

This study aims to learn more about the effects of aging and lip filler treatment on lips and the surrounding skin by comparing, among two different age groups of people, changes in the blood vessels and nerves, volume, color and texture change before and after lip filler treatment and pain tolerance from lip filler treatment.

Eligibility Criteria

Inclusion Criteria

  • Subjects must be able and willing to provide written informed consent and comply with the requirements of the study protocol;
  • In good general health, based on answers provided during the screening visit;
  • Subjects must be able to read and understand English;
  • Caucasian female;
  • Aged 21-30 years and post-menopausal;
  • Skin Types (all Fitzpatrick Skin Phototypes );
  • Smoking history is self-report.
  • Have very thin to moderately thick lips (Lip Fullness Grading Scale [LFGS] scores 0-2).

Exclusion Criteria

  • Participation in another investigational drug or device clinical trial in the past 30 days;
  • Are pregnant or lactating;
  • Intake of hormone replacement therapy (HRT) in the past 6 months;
  • Have a history of drug or alcohol abuse or have reported habitual alcohol intake greater than 2 standard drinks per day [e.g., 2 beers, 2 glasses of wine, or 2 mixed drinks];
  • Presence of eczema, psoriasis, or any other skin disease on the lips or perioral skin;
  • Have birth marks, tattoos, scars, or any other disfiguration of the skin in the skin area of interest;
  • Use of any anti-aging skin care products containing retinoic acid, retinol, or other retinoids (e.g. tazarotene, adapalene) or estrogen on the skin area of interest in the past 6 months;
  • Use of any prescription topical medication, such as corticosteroids or hydroquinone on the skin area of interest in the past 6 months;
  • Have a history of photodynamic therapy treatment or any skin rejuvenation procedure on the skin area of interest;
  • History of blood-clotting abnormality;
  • History of keloid formation or hypertrophic scarring;
  • Clinically significant abnormal findings or conditions which might, in the opinion of the Investigator, interfere with study evaluations or pose a risk to subject safety during the study;
  • Exhibits any clinical conditions or takes any medication which in the opinion of the investigator may interfere with the study or pose a risk to subject safety during the study;
  • Is not able to follow study protocol;
  • Have permanent lip implant, and lip enhancement or laser therapy performed within the preceding 12 months;
  • Known history of allergy or sensitivity to glycerol, Tegaderm, lidocaine, hyaluronic acid dermal fillers or materials with gram-positive bacterial proteins.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04839692). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search